Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
7DbCy6gGHRgnV8D7
Listen
